Almanack Investment Partners »

Nervgen Pharma Ord shares owned by Almanack Investment Partners

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Almanack Investment Partners from 13F filings

Historical chart of Almanack Investment Partners investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Almanack Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Almanack Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $79k 21k 3.77

More positions owned by Almanack Investment Partners

Ea Series Trust Gadsdn Dyn Mlt (GDMA)
Verizon Communications (VZ)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Schwab Strategic Tr Fundamental Emer (FNDE)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Msci Gbl Etf New (PICK)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Wisdomtree Tr Japn Hedge Eqt (DXJ)
Select Sector Spdr Tr State Street Ene (XLE)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Spdr Index Shs Fds State Street Spd (FEZ)
Global X Fds Glbl X Mlp Etf (MLPA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Almanack Investment Partners

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Marshall Wace
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
Captrust Financial Advisors
UBS Group
Advisor Group Holdings
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Traynor Capital Management

View all funds holding Nervgen Pharma Ord